Latest News for LUPIN.NS
/PRNewswire/ -- Lupin Limited (« Lupin »), géant pharmaceutique mondial (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) a annoncé
/PRNewswire/ -- Global pharma major Lupin Limited ("Lupin") (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced that VISUfarma
/PRNewswire/ -- Global pharmaceutical leader Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced that it
Lupin Announces U.S. FDA Approval and Launch of Sugammadex Injection PR Newswire MUMBAI, India and NAPLES, Fla., J
Lupin Announces the Approval of Diazepam Injection, USP in the United States PR Newswire MUMBAI, India, and NAPLES
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for LUPIN.NS.
Senate Trading
No Senate trades found for LUPIN.NS.
U.S. House Trading
No House trades found for LUPIN.NS.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.